XAIR on Nasdaq
Beyond Air, Inc.
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with INVO Fertility, Inc., InspireMD, Inc. or ENCISION INC, or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2026
3.3%Gross margin2
-378.2%Operating margin2
-433.0%Net margin2
107.3%Revenue growth, 20262
-542.8%Return on equity2
-$19.2MFree cash flow2
Where the money goes
Where each dollar of revenue went, fiscal 2026
- Cost of revenue20¢$7.4M
- Research and development28¢$10.2M
- Selling, general and admin52¢$19.1M
Out of $7.7M in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement in the latest annual report, as filed.2
| Period ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Revenues | $7.7M | $3.7M |
| Cost of revenues | $7.4M | $5.4M |
| Gross profit (loss) | $252.0K | -$1.7M |
| Research and development | $10.2M | $16.9M |
| Selling, general and administrative | $19.1M | $26.0M |
| Total operating expenses | $29.3M | $42.9M |
| Loss from operations | -$29.0M | -$44.5M |
| Dividend/investment income | $303.0K | $705.0K |
| Interest and finance expense | -$3.5M | -$3.0M |
| Change in fair value of warrant liability | $35.0K | $237.0K |
| Change in fair value of derivative liability | -$1.4M | $1.3M |
| Foreign exchange loss | -$108.0K | -$3.0K |
| Loss on extinguishment of debt | -$165.0K | -$2.4M |
| Loss on disposal/impairment of fixed assets | -$431.0K | -$738.0K |
| Other income/(expense) | -$14.0K | $9.0K |
| Total other income/(expense) | -$5.3M | -$3.9M |
| Loss before income taxes | -$34.3M | -$48.5M |
| Net loss | -$34.3M | -$48.5M |
| Less: net loss attributable to non-controlling interest | -$1.1M | -$1.9M |
| Net loss attributable to Beyond Air, Inc. | -$33.2M | -$46.6M |
| Foreign currency translation adjustment | $194.0K | -$45.0K |
| Comprehensive loss attributable to Beyond Air, Inc. | -$33.1M | -$46.7M |
| Net basic loss per share attributable to Beyond Air, Inc. | -$4.01 | -$13.77 |
| Net diluted loss per share attributable to Beyond Air, Inc. | -$4.01 | -$13.77 |
| Weighted average number of shares of common stock outstanding - basic | 8.3M shares | 3.4M shares |
| Weighted average number of shares of common stock outstanding - diluted | 8.3M shares | 3.4M shares |
Every line of the balance sheet in the latest annual report, as filed.2
| Period ending | 2026-03-31 | 2025-03-31 | 2024-03-31 |
|---|---|---|---|
| Cash and cash equivalents | $6.7M | $4.7M | |
| Marketable securities | $4.9M | $2.3M | |
| Restricted cash | $5.6M | $231.0K | |
| Accounts receivable, net | $1.1M | $710.0K | |
| Inventory, net | $1.4M | $2.4M | |
| Other current assets and prepaid expenses | $5.0M | $5.7M | |
| Total current assets | $24.8M | $16.0M | |
| Licensed right to use technology | $1.0M | $1.2M | |
| Right-of-use lease assets | $1.2M | $1.7M | |
| Property and equipment, net | $8.2M | $11.0M | |
| Other assets | $158.0K | $103.0K | |
| TOTAL ASSETS | $35.4M | $30.1M | |
| Accounts payable | $2.4M | $1.9M | |
| Accrued expenses and other current liabilities | $3.4M | $2.0M | |
| Operating lease liabilities, current portion | $321.0K | $396.0K | |
| Loans payable, current portion | $401.0K | $609.0K | |
| Total current liabilities | $6.5M | $5.0M | |
| Operating lease liabilities, net | $1.0M | $1.5M | |
| Long-term debt, net | $21.6M | $9.2M | |
| Warrant liability | $2.0K | $38.0K | |
| Total liabilities | $29.2M | $15.7M | |
| Common Stock, $0.0001 par value per share: 500,000,000 shares authorized, 11,792,684 and 4,128,539 shares issued and outstanding as of March 31, 2026 and 2025, respectively | $1.0K | ||
| Treasury stock | -$25.0K | -$25.0K | |
| Additional paid-in capital | $325.6M | $300.0M | |
| Accumulated deficit | -$319.6M | -$286.3M | |
| Accumulated other comprehensive income/(loss) | $134.0K | -$60.0K | |
| Total stockholders equity attributable to Beyond Air, Inc. | $6.1M | $13.6M | |
| Non-controlling interest | $84.0K | $758.0K | |
| Total stockholders equity | $6.2M | $14.3M | $27.2M |
| TOTAL LIABILITIES AND STOCKHOLDERS EQUITY | $35.4M | $30.1M | |
| Preferred stock, par value | $0.00 | $0.00 | |
| Preferred stock, shares authorized | 10.0M shares | 10.0M shares | |
| Preferred stock, shares issued | 0 shares | 0 shares | |
| Preferred stock, shares outstanding | 0 shares | 0 shares | |
| Common stock, par value | $0.00 | $0.00 | |
| Common stock, shares authorized | 500.0M shares | 500.0M shares | |
| Common stock, shares issued | 11.8M shares | 4.1M shares | |
| Common stock, shares outstanding | 11.8M shares | 4.1M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.2
| Period ending | 2026-03-31 | 2025-03-31 |
|---|---|---|
| Net loss | -$34.3M | -$48.5M |
| Depreciation | $3.0M | $3.0M |
| Stock-based compensation | $5.3M | $9.1M |
| Amortization of debt discount and accretion of debt issuance costs | $551.0K | $1.0M |
| Amortization of licensed right to use technology | $204.0K | $205.0K |
| Amortization of operating lease assets | $398.0K | $367.0K |
| Change in fair value of warrant liability | -$35.0K | -$237.0K |
| Change in fair value of derivative liability | $1.4M | -$1.3M |
| Unrealized loss on marketable securities | $60.0K | |
| Provision for inventory losses | $672.0K | $177.0K |
| Provision for bad debt | $91.0K | |
| Foreign currency adjustments | -$119.0K | |
| Loss on extinguishment of debt | $165.0K | $2.4M |
| Impairment of fixed assets | $505.0K | |
| Loss on disposal of fixed assets | $431.0K | $334.0K |
| Paid in kind interest | $1.8M | $696.0K |
| Inventory | $1.1M | -$466.0K |
| Accounts receivable | -$468.0K | -$390.0K |
| Other current assets and prepaid expenses | $683.0K | $1.0M |
| Accounts payable | $267.0K | $399.0K |
| Accrued expenses | $1.1M | -$6.4M |
| Operating lease liabilities | -$373.0K | -$385.0K |
| Net cash used in operating activities | -$18.1M | -$38.2M |
| Purchase of marketable securities | -$4.1M | -$30.9M |
| Proceeds from sale of marketable securities | $1.4M | $51.7M |
| Security deposits made on operating leases | $10.0K | |
| Purchase of property and equipment | -$1.0M | -$5.9M |
| Net cash (used in)/provided by investing activities | -$3.7M | $14.9M |
| Proceeds from issuance of common stock through at the market offerings, net | $8.1M | $2.2M |
| Proceeds from the sale of common stock of NeuroNos | $700.0K | $2.0M |
| Proceeds from issuance of common stock and pre-funded warrants through securities purchase, net | $4.5M | $18.9M |
| Proceeds from issuance of common stock through exercise of warrants | $2.9M | $365.0K |
| Proceeds from issuance of common stock warrants | $90.0K | |
| Proceeds from long term loan | $14.0M | $11.3M |
| Debt issuance costs | -$996.0K | |
| Payment of loan | -$208.0K | -$18.1M |
| Net cash provided by financing activities | $29.1M | $16.6M |
| Effect of exchange rate changes on cash and cash equivalents | $194.0K | -$45.0K |
| Increase/(decrease) in cash, cash equivalents and restricted cash | $7.5M | -$6.7M |
| Debt discount | $1.1M | $3.2M |
| Derivative liability | $775.0K | |
| Short term finance liability | $457.0K | $693.0K |
| Fixed assets recorded in accounts payable and accrued expenses | $398.0K | $396.0K |
| Right-of-use assets acquired under operating leases | $139.0K | |
| Debt principal balance converted to equity | $1.2M | |
| Interest paid | $423.0K | $1.2M |
Former names
Recent filings
- Oct 14, 20264 PRIMARY DOCUMENT
- Oct 8, 20268-K
- Oct 2, 2026SCHEDULE 13G/A
- Oct 2, 20263 PRIMARY DOCUMENT
- Oct 2, 20264 PRIMARY DOCUMENT
- Sep 24, 20268-K
- Aug 24, 2026424B3
- Aug 24, 2026EFFECT
- Aug 18, 20268-K
- Aug 17, 2026S-3
- Aug 14, 2026SCHEDULE 13G/A
- Aug 13, 202610-Q
- Aug 6, 20268-K
- Jul 31, 20268-K
- Jul 31, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12